What is he best known for?
The fields of study he is best known for:
- Gene
- Cancer
- Internal medicine
John D. Shaughnessy mainly investigates Multiple myeloma, Internal medicine, Gene expression profiling, Cancer research and Molecular biology.
He has researched Multiple myeloma in several fields, including Survival rate, Bone marrow, Immunopathology, Pathology and Cytogenetics.
His Internal medicine research includes themes of Surgery and Oncology.
His study in Gene expression profiling is interdisciplinary in nature, drawing from both Bioinformatics, Multivariate analysis, Genome, Comparative genomic hybridization and Regulation of gene expression.
He combines subjects such as Wnt signaling pathway, DKK1, Gene expression and Protein stabilization with his study of Cancer research.
John D. Shaughnessy has included themes like Positional cloning, Monoclonal gammopathy of undetermined significance and Cerebellar Degeneration, Cerebellum in his Molecular biology study.
His most cited work include:
- The Role of the Wnt-Signaling Antagonist DKK1 in the Development of Osteolytic Lesions in Multiple Myeloma (1245 citations)
- The molecular classification of multiple myeloma (804 citations)
- Frequent Engagement of the Classical and Alternative NF-κB Pathways by Diverse Genetic Abnormalities in Multiple Myeloma (803 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of investigation include Multiple myeloma, Internal medicine, Cancer research, Gene expression profiling and Oncology.
His research integrates issues of Bone marrow and Pathology in his study of Multiple myeloma.
He interconnects Gastroenterology and Surgery in the investigation of issues within Internal medicine.
His Cancer research research incorporates elements of Cell culture, Wnt signaling pathway, Osteoclast, Osteoblast and Molecular biology.
His research in Gene expression profiling intersects with topics in Computational biology, Disease and Bioinformatics.
His Oncology research is multidisciplinary, incorporating elements of Cancer, Clinical trial and Survival analysis.
He most often published in these fields:
- Multiple myeloma (64.44%)
- Internal medicine (38.50%)
- Cancer research (32.35%)
What were the highlights of his more recent work (between 2010-2021)?
- Multiple myeloma (64.44%)
- Internal medicine (38.50%)
- Cancer research (32.35%)
In recent papers he was focusing on the following fields of study:
Multiple myeloma, Internal medicine, Cancer research, Gene expression profiling and Oncology are his primary areas of study.
His Multiple myeloma research is within the category of Immunology.
His work on Hematology and Bortezomib is typically connected to Context as part of general Internal medicine study, connecting several disciplines of science.
The study incorporates disciplines such as Osteoclast, Bone disease, Stem cell and Autocrine signalling in addition to Cancer research.
The concepts of his Gene expression profiling study are interwoven with issues in DNA microarray, Computational biology, Chemotherapy and Fluorescence in situ hybridization.
The various areas that John D. Shaughnessy examines in his Oncology study include Monoclonal gammopathy of undetermined significance, Clinical trial, Dexamethasone, Risk stratification and Myeloma protein.
Between 2010 and 2021, his most popular works were:
- Consensus recommendations for risk stratification in multiple myeloma: report of the International Myeloma Workshop Consensus Panel 2 (253 citations)
- Proliferation is a central independent prognostic factor and target for personalized and risk-adapted treatment in multiple myeloma. (151 citations)
- Clinical, genomic, and imaging predictors of myeloma progression from asymptomatic monoclonal gammopathies (SWOG S0120) (124 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Cancer
- Internal medicine
John D. Shaughnessy mainly focuses on Multiple myeloma, Gene expression profiling, Immunology, Internal medicine and Oncology.
His studies in Multiple myeloma integrate themes in fields like Cancer, Cancer research, Stromal cell, Pathology and Bioinformatics.
His Gene expression profiling research includes elements of Computational biology, Cytokine and Gene isoform.
His work on Immunotherapy as part of general Immunology study is frequently connected to Interleukin-6 receptor, therefore bridging the gap between diverse disciplines of science and establishing a new relationship between them.
His biological study spans a wide range of topics, including Pharmacogenomics and Monoclonal.
His Oncology research is multidisciplinary, relying on both Monoclonal gammopathy of undetermined significance, Clinical trial, Disease and Bortezomib.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
